TLESR-impedance Study in Patients

NCT00743444 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Reflux Episodes

Interventions

DRUG: AZD3355
DRUG: Placebo

Sponsor

AstraZeneca